Tesamorelin: The FDA-Approved Peptide for Metabolic Health
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) and the only compound in its class to receive FDA approval. Originally approved in 2010 for treating excess abdominal fat in adults with HIV-associated lipodystrophy, it has since been studied for broader metabolic applications including non-alcoholic fatty liver disease, cognitive